Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Biotechnologie

Realtime-Estimate Cboe BZX Andere Börsenplätze 16:57:41 09.12.2024			% 5 Tage	% 1. Jan.
77,20 ^USD	+3,61 %		+1,83 %	+0,32 %

04.12.	Bio-Techne Corporation Presents at Citi's 2024 Global Healthcare Conference, Dec-04-2024 03:15 PM
25.11.	Bio-Techne erwirbt Produktrechte und Inventar an fötalem Rinderserum von Gemini Bioproducts	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE	27.11.
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum Product Rights and Inventory from Bio-Techne	26.11.
Bio-Techne's Select Fetal Bovine Serum Product Rights, Inventory Acquired by Gemini Bioproducts	25.11.
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne	25.11.
Gemini Bio-Products, Inc. acquired Assets of Bio-Techne Corporation.	25.11.
Bio-Techne Signs Distribution Deal With Leader Life Sciences	20.11.
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES	20.11.
Bio-Techne Corporation Announces New Distribution Agreement with Leader Life Sciences	20.11.
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH	18.11.
Bio-Techne Corporation and ALZpath, Inc Announce Strategic Partnership to Advance Neurodegenerative Disease Research	18.11.
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO	14.11.
Bio-Techne Corporation to Highlight Novel Solutions for Cancer and Carrier Screening At Amp 2024 Annual Meeting & Expo	14.11.
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex Grant	13.11.
UPDATED, BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS	12.11.
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS	11.11.
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES	11.11.
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS	11.11.
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES	08.11.
Bio-Techne Corporation - ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy	08.11.
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER 39TH ANNUAL MEETING	07.11.
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy	07.11.
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING	06.11.
Bio-Techne Corporation to Present at the Society for Immunotherapy of Cancer 39Th Annual Meeting	06.11.
Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on February 1, 2022.	05.11.
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH	05.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Biotechnologie

Andere Sprachen

Filter